XML 11 R1.htm IDEA: XBRL DOCUMENT v3.26.1
Cover - shares
 12 Months Ended
Mar. 31, 2026
Jul. 15, 2026
Entity Addresses [Line Items]    
Document Type 20-F/A  
Amendment Flag true  
Amendment Description This Amendment No. 1 on Form 20-F/A (the “Amended Annual Report”) amends the Annual Report on Form 20-F of OKYO Pharma Limited (the “Company” or “we”) for the year ended March 31, 2026 (the “Original Form 20-F”), filed on July 20, 2026, with the Securities and Exchange Commission (the “SEC”). The only changes made to the Original Form 20-F are to revise the Exhibit Table to include the Company’s Clawback policy, which was erroneously omitted from the previous filing. Except as noted above, the Company has not modified, or updated disclosures presented in this Amended Annual Report. Accordingly, the Amended Annual Report does not reflect events occurring after the Original Form 20-F or modify or update those disclosures affected by subsequent events.    
Document Registration Statement false  
Document Annual Report true  
Document Transition Report false  
Document Shell Company Report false  
Document Period End Date Mar. 31, 2026  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2026  
Current Fiscal Year End Date --03-31  
Entity File Number 001-41386  
Entity Registrant Name OKYO Pharma Limited  
Entity Central Index Key 0001849296  
Entity Incorporation, State or Country Code Y7  
Entity Address, Address Line One OKYO Pharma Limited  
Entity Address, Address Line Two Martello Court  
Entity Address, Address Line Three Admiral Park  
Entity Address, City or Town St. Peter Port  
Entity Address, Country GG  
Entity Address, Postal Zip Code GY1 3HB  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Document Accounting Standard International Financial Reporting Standards  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   52,479,527
ICFR Auditor Attestation Flag false  
Document Financial Statement Error Correction [Flag] false  
Business Contact [Member]    
Entity Addresses [Line Items]    
Entity Address, Address Line One 107 Cheapside  
Entity Address, City or Town London  
Entity Address, Country GB  
Entity Address, Postal Zip Code EC2V 6DN  
City Area Code +44  
Local Phone Number 20 7495 2379  
Contact Personnel Name Chief Financial Officer  
Contact Personnel Email Address kshah@okyopharma.com